Association of OGG1 Ser326Cys polymorphism and pancreatic cancer susceptibility: Evidence from a meta-analysis

Tumor Biology

Volumn 35, Issue 3, 2014, Pages 2397-2402

  Yan, Yulan ^a   Chen, Xu ^a   Li, Taijie ^a   Li, Meng ^a   Liang, Hongjie ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; OGG1; Pancreatic cancer; Polymorphism

Indexed keywords

8 OXOGUANINE DNA GLYCOSYLASE GENE; ARTICLE; CANCER SUSCEPTIBILITY; ETHNICITY; GENE; GENETIC POLYMORPHISM; HUMAN; PANCREAS CANCER; PRIORITY JOURNAL; SAMPLE SIZE;

CASE-CONTROL STUDIES; DNA GLYCOSYLASES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ODDS RATIO; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84899058897     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1317-7     Document Type: Article

References (36)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
3. Ghaneh P, Costello E, Neoptolemos JP. Biology and management of pancreatic cancer. Gut. 2007;56:1134-52.
4. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29.
5. Hariharan D, Saied A, Kocher HM. Analysis of mortality rates for pancreatic cancer across the world. HPB: Off J Int Hepato Pancreato Biliary Assoc. 2008;10:58-62.
6. Le Scodan R, Mornex F, Girard N, Mercier C, Valette PJ, Ychou M, et al. Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review. Ann Oncol: Off J Eur Soc Med Oncol/ESMO. 2009;20:1387-96.
7. Bednar F, Simeone DM. Pancreatic cancer stem cell biology and its therapeutic implications. J Gastroenterol. 2011;46:1345-52.
8. Gutierrez ML, Munoz-Bellvis L, Abad Mdel M, Bengoechea O, Gonzalez-Gonzalez M, Orfao A, et al. Association between genetic subgroups of pancreatic ductal adenocarcinoma defined by high density 500 k SNP-arrays and tumor histopathology. PLoS One. 2011;6:e22315.
9. Rizzato C, Campa D, Giese N, Werner J, Rachakonda PS, Kumar R, et al. Pancreatic cancer susceptibility loci and their role in survival. PLoS One. 2011;6:e27921.
10. Lucenteforte E, La Vecchia C, Silverman D, Petersen GM, Bracci PM, Ji BT, et al. Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PANC4). Ann Oncol: Off J Eur Soc Med Oncol / ESMO. 2012;23:374-82.
11. Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbeck's Arch Surg/Deut Ges Chir. 2008;393:535-45.
12. Aune D, Chan DS, Vieira AR, Navarro Rosenblatt DA, Vieira R, Greenwood DC, et al. Dietary fructose, carbohydrates, glycemic indices and pancreatic cancer risk: a systematic review and meta-analysis of cohort studies. Ann Oncol: Off J Eur Soc Med Oncol / ESMO. 2012;23:2536-46.
13. Li G, Chen Q, Wang L, Ke D, Yuan Z. Association between FTO gene polymorphism and cancer risk: evidence from 16,277 cases and 31,153 controls. Tumour Biol: J Int Soc Oncodev Biol Med. 2012;33:1237-43.
14. Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, Peters U. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA: J Am Med Assoc. 2008;299:2423-36.
15. Yun SJ, Ha YS, Chae Y, Kim JS, Kim IY, Kim WJ. The hOGG1 mutant genotype is associated with prostate cancer susceptibility and aggressive clinicopathological characteristics in the Korean population. Ann Oncol: Off J Eur Soc Med Oncol / ESMO. 2012;23:401-5.
16. Yang N, Chaudhry MA, Wallace SS. Base excision repair by hNTH1 and hOGG1: a two edged sword in the processing of DNA damage in gamma-irradiated human cells. DNA Repair. 2006;5:43-51.
17. Dherin C, Radicella JP, Dizdaroglu M, Boiteux S. Excision of oxidatively damaged DNA bases by the human alpha-hOGG1 protein and the polymorphic alpha-hOGG1(ser326cys) protein which is frequently found in human populations. Nucleic Acids Res. 1999;27:4001-7.
18. Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, et al. The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004;14:2121-7.
19. Vodicka P, Stetina R, Polakova V, Tulupova E, Naccarati A, Vodickova L, et al. Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis. 2007;28:657-64.
20. Weiss JM, Goode EL, Ladiges WC, Ulrich CM. Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol Carcinog. 2005;42:127-41.
21. Kohno T, Shinmura K, Tosaka M, Tani M, Kim SR, Sugimura H, et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene. 1998;16:3219-25.
22. Nakao M, Hosono S, Ito H, Watanabe M, Mizuno N, Sato S, et al. Selected polymorphisms of base excision repair genes and pancreatic cancer risk in Japanese. J Epidemiol/Jpn Epidemiol Assoc. 2012;22:477-83.
23. Li D, Suzuki H, Liu B, Morris J, Liu J, Okazaki T, et al. DNA repair gene polymorphisms and risk of pancreatic cancer. Clin Cancer Res: Off J Am Assoc Cancer Res. 2009;15:740-6.
24. Duell EJ, Bracci PM, Moore JH, Burk RD, Kelsey KT, Holly EA. Detecting pathway-based gene-gene and gene-environment interactions in pancreatic cancer. Cancer Epidemiol Biomarkers Prev: Publ Am Assoc Cancer Res CoCosponsored Am Soc Prev Oncol. 2008;17:1470-9.
25. McWilliams RR, Bamlet WR, Cunningham JM, Goode EL, de Andrade M, Boardman LA, et al. Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res. 2008;68:4928-35.
26. Zhang J, Zhang X, Dhakal IB, Gross MD, Kadlubar FF, Anderson KE. Sequence variants in antioxidant defense and DNA repair genes, dietary antioxidants, and pancreatic cancer risk. Int J Mol Epidemiol Genet. 2011;2:236-44.
27. Cochran WG. The comparison of percentages in matched samples. Biometrika. 1950;37:256-66.
28. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
29. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
30. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34.
31. Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316:469. author reply 470-461.
32. Tobias A, Campbell MJ. Modelling influenza epidemics in the relation between black smoke and total mortality. A sensitivity analysis. J Epidemiol Community Health. 1999;53:583-4.
33. Yuan W, Xu L, Feng Y, Yang Y, Chen W, Wang J, et al. The hOGG1 ser326cys polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;122:835-42.
34. Zhang Y, He BS, Pan YQ, Xu YQ, Wang SK. Association of OGG1 Ser326cys polymorphism with colorectal cancer risk: a meta-analysis. Int J Color Dis. 2011;26:1525-30.
35. Wang Z, Hu J, Cai W, Zhong J. Lack of association between the 8-oxoguanine DNA glycosylase gene ser326cys polymorphism and gastric cancer: evidence from a meta-analysis. Asian Pac J Cancer Prev: APJCP. 2011;12:3427-31.
36. Duan WX, Hua RX, Yi W, Shen LJ, Jin ZX, Zhao YH, et al. The association between ogg1 ser326cys polymorphism and lung cancer susceptibility: a meta-analysis of 27 studies. PLoS One. 2012;7:e35970.